Richard J Riese

Title: Richard J Riese: Innovator in Immune Response Suppression

Introduction

Richard J Riese is a notable inventor based in Brookline, MA (US), recognized for his contributions to the field of immunology. He holds a total of 3 patents, focusing on innovative methods for suppressing immune responses, particularly through the inhibition of cathepsin S.

Latest Patents

Riese's latest patents detail methods and products aimed at suppressing a class II MHC-restricted immune response in mammals. These methods involve inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes. This inhibition reduces the competency of class II MHC molecules for binding antigenic peptides, thereby decreasing the presentation of these peptides and suppressing immune responses. The applications of these methods are significant, as they may be employed in treating autoimmune diseases, allergic responses, and organ or tissue graft rejection. Additionally, pharmaceutical and therapeutic compositions that are peptide-based inhibitors of cathepsin S are also described in his patents.

Career Highlights

Throughout his career, Richard J Riese has worked with prestigious institutions, including Brigham and Women's Hospital and the Massachusetts Institute of Technology. His work has significantly advanced the understanding and treatment of immune-related conditions.

Collaborations

Riese has collaborated with esteemed colleagues such as Hidde L Ploegh and Harold A Chapman, contributing to the development of innovative solutions in immunology.

Conclusion

Richard J Riese's work in the field of immune response suppression showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving treatments for various immune-related conditions.